全文获取类型
收费全文 | 2562751篇 |
免费 | 196425篇 |
国内免费 | 4184篇 |
专业分类
耳鼻咽喉 | 36361篇 |
儿科学 | 85479篇 |
妇产科学 | 73997篇 |
基础医学 | 368950篇 |
口腔科学 | 74668篇 |
临床医学 | 223876篇 |
内科学 | 496863篇 |
皮肤病学 | 54787篇 |
神经病学 | 204733篇 |
特种医学 | 101098篇 |
外国民族医学 | 800篇 |
外科学 | 391276篇 |
综合类 | 59863篇 |
现状与发展 | 4篇 |
一般理论 | 812篇 |
预防医学 | 195957篇 |
眼科学 | 59750篇 |
药学 | 194065篇 |
4篇 | |
中国医学 | 4783篇 |
肿瘤学 | 135234篇 |
出版年
2018年 | 23919篇 |
2015年 | 23968篇 |
2014年 | 33051篇 |
2013年 | 50445篇 |
2012年 | 68732篇 |
2011年 | 73151篇 |
2010年 | 43123篇 |
2009年 | 40978篇 |
2008年 | 70274篇 |
2007年 | 75064篇 |
2006年 | 76338篇 |
2005年 | 74402篇 |
2004年 | 72638篇 |
2003年 | 69826篇 |
2002年 | 68648篇 |
2001年 | 115836篇 |
2000年 | 119367篇 |
1999年 | 101382篇 |
1998年 | 28552篇 |
1997年 | 25794篇 |
1996年 | 25885篇 |
1995年 | 24896篇 |
1994年 | 23439篇 |
1993年 | 22010篇 |
1992年 | 83524篇 |
1991年 | 81667篇 |
1990年 | 80308篇 |
1989年 | 77796篇 |
1988年 | 72429篇 |
1987年 | 71444篇 |
1986年 | 68001篇 |
1985年 | 65340篇 |
1984年 | 49061篇 |
1983年 | 42622篇 |
1982年 | 25163篇 |
1981年 | 22378篇 |
1980年 | 21069篇 |
1979年 | 47029篇 |
1978年 | 32889篇 |
1977年 | 28025篇 |
1976年 | 26524篇 |
1975年 | 28457篇 |
1974年 | 34251篇 |
1973年 | 33074篇 |
1972年 | 30966篇 |
1971年 | 28915篇 |
1970年 | 26796篇 |
1969年 | 25335篇 |
1968年 | 23484篇 |
1967年 | 21054篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Evelien R. Spelten Chantal R. M. Lammens Vivian Engelen Saskia F. A. Duijts 《Journal of psychosocial oncology》2020,38(1):36-62
AbstractPurpose: While a wide range of psychosocial oncological (PO) interventions has been developed, a systematic overview of interventions to inform patients, care providers, as well as researchers, policy makers and health insurers, is lacking. The aims of this paper were (1) to describe the attainment of this overview, which may be used in other jurisdictions and for other health conditions and (2) to reflect on what determines developments in this field.Methods: Dutch researchers and care providers were invited to describe PO-interventions they apply in research or clinical practice. Selection criteria for what constituted a PO-intervention were determined. The input was organized in 12 predefined categories (e.g. physical functioning, genetics).Findings: Sixty-six PO-interventions were included in the overview. Two major categories were psychosocial functioning (24%) and physical functioning and recovery (24%). Interventions are mostly directed at adults (65%) and not aimed at a specific type of cancer (61%). Nearly 25% of the interventions lacked scientific underpinning.Conclusions: This paper provides an overview of Dutch PO-interventions and input on what drives their development. The categorizing method can be used in other jurisdictions and for other health care conditions. A next step would be to investigate the effectiveness and evidence of PO-interventions.Implications for Psychosocial Providers and Policy: The open access overview of interventions provides referral information for care providers. By identifying possible gaps and overlap, the overview looks at possible drivers behind developments in this field which will be of interest to policy makers. 相似文献
102.
K.A. Lee M.T.A. Sharabiani D. Tumino J. Wadsley V. Gill G. Gerrard R. Sindhu M.N. Gaze L. Moss K. Newbold 《Clinical oncology (Royal College of Radiologists (Great Britain))》2019,31(6):385-390
Aims
To obtain an overview of the management and outcomes of children aged 18 years or younger diagnosed with differentiated thyroid carcinoma of follicular cell origin across the UK, by collecting and analysing data from the limited number of centres treating these patients. This multicentre data might provide a more realistic perspective than single-institution series.Materials and methods
Six centres submitted data extracted from historical records on patients aged 18 years or younger, diagnosed between 1964 and 2017. The univariate and multivariable Cox proportional hazard model was used to identify potential predictors of progression-free survival, using national data as a control.Results
Data on 166 patients were available for analysis. Females (74%) were predominant, and the age ranged from 3 to 19 years at diagnosis, mean 14.1 years. Nodal metastases were present in 51%; 12% had distant metastases. After surgery, 95% received radioactive iodine (39% on more than one occasion) and 4% received external beam radiotherapy. With a median follow-up duration of 5 years, 69% are alive with no evidence of disease; 20% are alive with a raised thyroglobulin level as the only evidence of residual disease; 6% have residual structural disease detectable on imaging; 2% have died, from cerebral metastases.Conclusion
Despite most patients having advanced disease at presentation, outcomes are very good. A national prospective registry should allow systematic collection of good-quality data and may facilitate research to further improve outcomes. 相似文献103.
104.
105.
Sarah J. Schrauben Haochang Shou Xiaoming Zhang Amanda Hyre Anderson Joseph V. Bonventre Jing Chen Steven Coca Susan L. Furth Jason H. Greenberg Orlando M. Gutierrez Joachim H. Ix James P. Lash Chirag R. Parikh Casey M. Rebholz Venkata Sabbisetti Mark J. Sarnak Michael G. Shlipak Sushrut S. Waikar Paul L. Kimmel Ramachandran S. Vasan Harold I. Feldman Jeffrey R. Schelling 《Journal of the American Society of Nephrology : JASN》2021,32(1):115
106.
107.
108.
109.
110.